| Literature DB >> 30621124 |
Indira Paz-Graniel1, Nancy Babio2,3, Ignacio Mendez4, Jordi Salas-Salvadó5,6.
Abstract
Cardiovascular disease (CVD) is one of the main causes of morbidity and mortality around the world. Lifestyle is recognized as a key factor in the development of metabolic disorders and CVD. Recently, eating speed has been of particular interest since some studies have associated it with the development of obesity and other cardiometabolic disorders. We aimed to assess the association between eating speed and various cardiovascular risk factors. We conducted a cross-sectional analysis within the framework of the PREDIMED (Prevención con Dieta Mediterránea) study with 792 participants from the Reus-Tarragona center. Eating speed was self-reported according to participant perception and categorized as slow, medium, or fast. The association between eating speed and cardiovascular risk factors was assessed using Cox regression models with constant time of follow-up for all individuals. Compared to participants in the slow eating speed category, those in the faster eating speed category were 59% more likely to have the hypertriglyceridemia component of the metabolic syndrome (MetS) (Hazard Ratio, (HR) 1.59; 95% Confidence Interval (CI) 1.16⁻2.17), even after adjustment for potential confounders (HR 1.47; 95% CI 1.08⁻2.02). No other significant differences were observed. Eating speed was positively associated with the prevalence of the hypertriglyceridemia component of the MetS in a senior population at high cardiovascular risk.Entities:
Keywords: PREDIMED study; eating speed; hypertriglyceridemia; metabolic syndrome
Mesh:
Year: 2019 PMID: 30621124 PMCID: PMC6356451 DOI: 10.3390/nu11010083
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
General characteristics of the study population across self-reported eating speed categories.
| Eating Speed Categories | ||||
|---|---|---|---|---|
| Slow | Medium | Fast | ||
| Women, % ( | 54.70 (99) | 49.40 (124) | 63.61 (229) | <0.01 |
| Age, years | 68.82 ± 5.72 | 68.20 ± 5.81 | 66.37 ± 5.78 | <0.01 |
| BMI (kg/m2) | 29.19 ± 3.50 | 29.40 ± 3.14 | 30.00 ± 3.32 | 0.01 |
| Obesity, % ( | 41.44 (75) | 41.04 (103) | 50.56 (182) | 0.03 |
| Waist circumference (cm) | ||||
| Women | 99.23 ± 9.65 | 98.27 ± 7.80 | 99.79 ± 8.56 | 0.28 |
| Men | 102.74 ± 9.03 | 103.37 ± 8.45 | 103.24 ± 8.41 | 0.87 |
| Smokers, % ( | ||||
| Current | 10.50 (19) | 13.55 (34) | 10.28 (37) | 0.24 |
| Former | 26.52 (48) | 27.09 (68) | 21.67 (78) | |
| Never smoker | 62.98 (114) | 59.36 (149) | 68.06 (245) | |
| Physical activity, MET/min/day | 264 ± 217 | 291 ± 311 | 250 ± 259 | 0.19 |
| Education level, % ( | ||||
| Low-medium | 92.82 (168) | 94.82 (238) | 93.61 (337) | 0.68 |
| High | 7.18 (13) | 5.18 (13) | 6.39 (23) | |
| Prosthesis use, % ( | 59.67 (108) | 54.18 (136) | 46.94 (169) | 0.02 |
|
| ||||
| Oral antidiabetics | 38.12 (69) | 34.26 (86) | 32.22 (116) | 0.39 |
| Insulin | 7.73 (14) | 5.98 (15) | 6.11 (22) | 0.72 |
| Hypocholesterolemic agents | 38.12 (69) | 45.02 (113) | 47.22 (170) | 0.13 |
| Antihypertensive agents | 72.93 (132) | 74.50 (187) | 75.28 (271) | 0.84 |
|
| ||||
| Glucose, mg/dL | 123.57 ± 46.66 | 121.83 ± 36.98 | 118.47 ± 36.00 | 0.31 |
| Triglycerides, mg/dL—median (IQR) b | 107.60 [76.00–141.97] | 120.90 [87.94–154.89] | 122.32 [92.73–166.10] | <0.01 |
| Total cholesterol, mg/dL | 207.95 ± 39.15 | 208.38 ± 40.26 | 209.67 ± 36.62 | 0.86 |
| HDL-cholesterol, mg/dL—median (IQR) | ||||
| Women | 58.13 [48.00–65.70] | 56.09 [49.90–66.61] | 55.34 [48.98–65.57] | 0.50 |
| Men | 51.85 [44.08–58.80] | 48.10 [42.30–55.34] | 48.74 [42.00–55.98] | 0.03 |
| Systolic blood pressure, mmHg | 151.59 ± 19.23 | 150.46 ± 17.86 | 149.72 ± 18.26 | 0.53 |
| Diastolic blood pressure, mmHg | 81.83 ± 10.75 | 82.99 ± 9.24 | 84.13 ± 9.09 | 0.03 |
Data are expressed as mean ± SD for continuous variables and percentages, number (n) for categorical variables and median (IQR). a p value was calculated by the chi-square or ANOVA test for categorical and continuous variables, respectively. b Variables transformed logarithmically before analysis. Abbreviations: MET, Metabolic Equivalent Task; HDL, High Density Lipoprotein; IQR: Interquartile Range
Dietary characteristics of the study population across self-reported eating speed categories.
| Eating Speed Categories | ||||
|---|---|---|---|---|
| Slow | Medium | Fast | ||
| MedDiet b adherence (0–14 points) | 8.18 ± 1.97 | 8.34 ± 1.99 | 8.22 ± 1.83 | 0.64 |
| Energy intake (Kcal) | 2290 ± 512 | 2271 ± 557 | 2282 ± 533 | 0.94 |
| Eating frequency, % ( | ||||
| 1–2 meals/day | 15.17 (27) | 12.75 (32) | 19.17 (69) | 0.10 |
| >3 meals/day | 84.83 (151) | 87.25 (219) | 80.83 (291) | |
| Macronutrient distribution | ||||
| Carbohydrate (g/day) | 228 ± 66 | 227 ± 68 | 231 ± 72 | 0.75 |
| Carbohydrate, % of total energy | 39.85 ± 6.68 | 39.84 ± 6.12 | 40.23 ± 6.57 | 0.70 |
| Protein (g/day) | 93 ± 22 | 93 ± 21 | 95 ± 21 | 0.23 |
| Protein, % of total energy | 16.40 ± 2.57 | 16.59 ± 2.40 | 17.00 ± 2.58 | 0.02 |
| Lipid (g/day) | 103 ± 26 | 104 ± 29 | 103 ± 27 | 0.95 |
| Lipid, % of total energy | 40.77 ± 6.19 | 41.00 ± 5.93 | 40.71 ± 6.21 | 0.84 |
| Dietary fiber (g/day) | 23.03 ± 7.54 | 23.18 ± 7.87 | 23.68 ± 7.65 | 0.58 |
| Alcohol intake (g/day) | 10.65 ± 17.53 | 8.88 ± 12.41 | 7.33 ± 12.36 | 0.03 |
Data are expressed as mean ± SD for continuous variables and percentages and numbers (n) for categorical variables. a p value was calculated by chi-square or ANOVA test for categorical and continuous variables, respectively. b Mediterranean Diet.
Hazard ratio (95% CI) of different cardiovascular risk factors for self-reported eating speed categories.
| Eating Speed Categories | |||
|---|---|---|---|
| Slow | Medium | Fast | |
| Obesity % ( | 41.4 (75) | 41 (103) | 50.6 (182) |
| Crude model | 1 (Ref.) | 0.99 (0.79–1.24) | 1.22 (1.00–1.49) |
| Adjusted model a | 1 (Ref.) | 0.99 (0.80–1.24) | 1.15 (0.94–1.40) |
| Metabolic syndrome % ( | 59.70 (108) | 61.00 (153) | 64.40 (232) |
| Crude model | 1 (Ref.) | 1.02 (0.88–1.19) | 1.08 (0.94–1.24) |
| Adjusted model b | 1 (Ref.) | 1.02 (0.88–1.18) | 0.99 (0.86–1.14) |
|
| |||
| Central obesity % ( | 74.60 (135) | 74.10 (186) | 78.90 (284) |
| Crude model | 1 (Ref.) | 0.99 (0.89–1.11) | 1.06 (0.95–1.17) |
| Adjusted model b | 1 (Ref.) | 1.00 (0.91–1.10) | 0.95 (0.87–1.04) |
| Hypertriglyceridemia % ( | 21.60 (39) | 29.10 (73) | 34.20 (123) |
| Crude model | 1 (Ref.) | 1.35 (0.97–1.89) | 1.59 (1.16–2.17) |
| Adjusted model b | 1 (Ref.) | 1.32 (0.95–1.85) | 1.47 (1.08–2.02) |
| Low HDL-C % ( | 22.10 (40) | 21.10 (53) | 23.90 (86) |
| Crude model | 1 (Ref.) | 0.96 (0.67–1.37) | 1.08 (0.78–1.50) |
| Adjusted model b | 1 (Ref.) | 0.96 (0.68–1.37) | 0.94 (0.68–1.30) |
| High Blood Pressure % ( | 96.10 (174) | 95.60 (240) | 96.40 (347) |
| Crude model | 1 (Ref.) | 0.99 (0.96–1.03) | 1.00 (0.97–1.04) |
| Adjusted model b | 1 (Ref.) | 1.00 (0.96–1.03) | 1.00 (0.97–1.04) |
| High fasting glucose % ( | 65.20 (118) | 65.70 (165) | 61.10 (220) |
| Crude model | 1 (Ref.) | 1.01 (0.88–1.16) | 0.94 (0.82–1.07) |
| Adjusted model b | 1 (Ref.) | 1.00 (0.87–1.15) | 0.92 (0.80–1.06) |
Abbreviations: CI, confidence interval. a Model 1 adjusted for sex (female or male), age (years), educational level (low-medium, or high), smoking (current, former, or never), total energy intake, physical activity, oral prosthesis use (yes or no), alcohol consumption (g/d), MedDiet adherence (low or high). b Model 2 adjusted for variables from model 1. Additionally adjusted by BMI. All analyses were conducted with robust estimates of the variance to correct for intra-cluster correlation in the Cox regression models.